CEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...

Quote of the Day: Franz Kafka, a renowned writer, explored themes of isolation and anxiety. His quote suggests that avoiding the world's su...

Weight loss: A new study is challenging the popular “10,000 steps a day” rule, suggesting you may not need that much to protect your progre...

India's drug regulator has issued a new directive for pharmaceutical companies. Periodic Safety Update Reports for new drugs must now be su...

Pfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...

"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...

The Indian government is shaking up the pharmaceutical sector by slashing the review period for manufacturing applications for new drugs to...

The Indian government is amending drug regulations to expedite the approval process for clinical trials and bioavailability/bioequivalence ...

The Supreme Court has instructed the Centre to respond within four weeks to a PIL filed by Swasthya Adhikar Manch against unethical clinica...

Healthcare experts suggest that India could increase its share in the global clinical trials market by learning from countries like China a...

India's regulatory reforms since 2013 and the New Drugs and Clinical Trial Rules of 2019 have made it an attractive destination for clinica...

A day before India begins the world’s largest Covid-19 vaccination drive, a group of healthcare-focused NGOs has sought clarifications from...

The ministry of health and family welfare is amending the New Drugs and Clinical Trials Rules 2019, enabling any government or private hosp...

The new rules will ensure patient safety, as they would be enlisted for trials with informed consent.

Ethics committee, registered with DCGI according to the Drugs & Cosmetics Rules, can also decide whether a site is suitable for conducting ...

As per the proposed rule, an independent expert committee will examine the reported adverse events and make recommendations to the DCGI.

Minister for Science & Technology Kapil Sibal believes India is emerging as a global pharma research hub.